Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
+12.02%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$64.6B
AUM Growth
+$5.95B
Cap. Flow
+$253M
Cap. Flow %
0.39%
Top 10 Hldgs %
11.91%
Holding
4,318
New
705
Increased
1,592
Reduced
1,357
Closed
634

Sector Composition

1 Technology 19.76%
2 Healthcare 17.68%
3 Consumer Discretionary 13.1%
4 Industrials 7.95%
5 Consumer Staples 7.93%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ADIL
3476
Adial Pharmaceuticals
ADIL
$7.64M
$43K ﹤0.01%
+23,200
New +$43K
PERF icon
3477
Perfect Corp
PERF
$190M
$43K ﹤0.01%
+14,000
New +$43K
SABS icon
3478
SAB Biotherapeutics
SABS
$22.2M
$43K ﹤0.01%
6,310
+500
+9% +$3.41K
ABVC icon
3479
ABVC BioPharma
ABVC
$63.1M
$42K ﹤0.01%
+36,100
New +$42K
LIQT icon
3480
LiqTech
LIQT
$23.2M
$42K ﹤0.01%
12,228
-7,242
-37% -$24.9K
NSPR icon
3481
InspireMD
NSPR
$100M
$42K ﹤0.01%
15,000
-1,700
-10% -$4.76K
OTLK icon
3482
Outlook Therapeutics
OTLK
$44.4M
$42K ﹤0.01%
+5,271
New +$42K
SOL
3483
Emeren Group
SOL
$96.5M
$42K ﹤0.01%
15,400
-9,240
-38% -$25.2K
NBSE
3484
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$42K ﹤0.01%
+56,967
New +$42K
FNCH
3485
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$42K ﹤0.01%
+11,746
New +$42K
DPRO
3486
Draganfly
DPRO
$91.5M
$41K ﹤0.01%
+3,441
New +$41K
RBBN icon
3487
Ribbon Communications
RBBN
$699M
$41K ﹤0.01%
14,000
-17,600
-56% -$51.5K
NXTP
3488
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$41K ﹤0.01%
+17,735
New +$41K
SALM
3489
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$41K ﹤0.01%
106,100
+1,900
+2% +$734
LABP
3490
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$41K ﹤0.01%
11,260
+1,000
+10% +$3.64K
AMTD
3491
AMTD IDEA Group
AMTD
$91.5M
$40K ﹤0.01%
+22,333
New +$40K
BRCC icon
3492
BRC Inc
BRCC
$174M
$40K ﹤0.01%
+11,036
New +$40K
IDAI icon
3493
T Stamp
IDAI
$8.21M
$40K ﹤0.01%
+1,947
New +$40K
SANW
3494
DELISTED
S&W Seed Co
SANW
$40K ﹤0.01%
2,984
+299
+11% +$4.01K
CYCC icon
3495
Cyclacel Pharmaceuticals
CYCC
$15.2M
$39K ﹤0.01%
60
+8
+15% +$5.2K
HYFT
3496
MindWalk Holdings Corp. Common Stock
HYFT
$88.2M
$39K ﹤0.01%
23,000
+8,400
+58% +$14.2K
SGRP icon
3497
SPAR Group
SGRP
$27.7M
$39K ﹤0.01%
39,000
+1,800
+5% +$1.8K
VBIV
3498
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$39K ﹤0.01%
66,842
+39,500
+144% +$23K
EVGN icon
3499
Evogene
EVGN
$11.2M
$38K ﹤0.01%
4,480
-60
-1% -$509
ATON
3500
AlphaTON Capital Corp. Common Stock
ATON
$13.2M
$38K ﹤0.01%
1,055
+355
+51% +$12.8K